Item 8.01 Other Events OnJuly 15, 2021 ,Ocugen, Inc. (the "Company") issued a press release announcing that it had initiated a rolling submission toHealth Canada for COVAXIN™, the Company's candidate vaccine against COVID-19, which it is co-developing withBharat Biotech International Limited for theU.S. and Canadian markets. A copy of this press release is filed herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Additionally, attached as Exhibit 99.2 and incorporated herein by reference is a presentation that the Company will post on its website onJuly 15, 2021 and may use from time to time in presentations or discussions with investors, analysts, and other parties. Item 9.01 Financial Statements and Exhibits The following exhibits are being filed herewith: (d) Exhibits Exhibit No. Document 99.1 Press release ofOcugen, Inc. datedJuly 15, 2021 99.2Ocugen, Inc. Presentation 104 Cover Page Interactive Data File (embedded
within the Inline XBRL document)
1
--------------------------------------------------------------------------------
© Edgar Online, source